RhythMedix launches next-gen RhythmStar Device

RhythMedix, a leader in remote cardiac monitoring released a next-generation RhythmStar wearable device with built-in 4G cellular connectivity. The novel cardiac telemetry monitor is discreetly worn for remote monitoring without the need for an additional phone or communication device. The technology enables rapid ECG analysis and reporting of cardiac abnormalities by RhythMedix’s team of US-based certified technicians, who alert physicians if an arrhythmia of concern is detected. RhythmStar is available with HeartTime on-demand telemetry mode, an innovative platform that allows physicians to evaluate the cardiac activity and expedite care via a telemedicine appointment. 

Steven DaTorre, M.D., Clinical Cardiologist, Cooper University Health Care in New Jersey, said: “The novel wearable RhythmStar monitoring device offers increased patient compliance and allows for accurate assessment of cardiac rhythm in real-time. It also allows me to remain connected to my patients throughout their monitoring period, which may expedite a life-saving diagnosis.”  

The sleek, one-piece device, with built-in 4G cellular technology, is the first wearable multi-modality cardiac monitor, that connects patients and clinicians for improved patient care. RhythmStar integrates seamlessly into clinical practice, helping physicians make informed treatment decisions that allow patients to enjoy life without missing a beat.

Brian Pike, President, Chief Operations Officer, and Co-Founder, RhythMedix, said: “We are excited to offer physicians and their patients our unique monitoring solution that improves patient compliance, help accelerate diagnosis, and allows physicians to stay virtually connected to their patients with on-demand access to clinical data. We look forward to bringing this next-generation RhythmStar technology to physicians across the U.S. in 2021.”

Leave a Reply